Olesen H, Cowan D, Bruunshuus I, Klempel K, Hill G
Dept. Clinical Pharmacology Q, Copenhagen University Hospital (Rigshospitalet), Denmark.
Clin Chim Acta. 1997 Dec 10;268(1-2):S5-73. doi: 10.1016/s0009-8981(97)00145-9.
The term designating a substance being an active ingredient of a drug may be a generic name, a nonproprietary name, a registered trade name, a fantasy name or other. This causes difficulties in the transmission of request and report on such substances to and from the clinical laboratories, and in the collating of this information from different sources. The document comprises a list of properties of drugs of abuse in biological fluids as defined by the International Olympic Committee Medical Code for use in electronic transmission systems. Standard systematic names are presented with a code value for each. The coding schemes thus prepared are accessible on Internet from C-NPU Home page address: http://inet.uni-c.dk/ qukb7642.
指定一种物质为药物活性成分的术语可以是通用名、非专利名、注册商品名、虚构名或其他名称。这给临床实验室之间传递关于此类物质的请求和报告以及整合来自不同来源的这些信息带来了困难。该文件包含国际奥委会医学规范所定义的生物体液中滥用药物特性列表,供电子传输系统使用。给出了每种药物的标准系统名称及其代码值。通过互联网可从C-NPU主页地址:http://inet.uni-c.dk/ qukb7642访问这样编制的编码方案。